Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study

BACKGROUND: Despite the latest World Health Organization guidelines advocating daily therapy in HIV-TB co-infected individuals, there are few recent studies comparing outcomes of thrice-weekly anti-tuberculosis treatment in HIV-positive and HIV-negative patients with TB. The present study sets out t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vashishtha, Richa, Mohan, Krishna, Singh, Bhagteshwar, Devarapu, Satish K, Sreenivas, Vishnubhatla, Ranjan, Sanjay, Gupta, Deepak, Sinha, Sanjeev, Sharma, Surendra K
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3852441/
https://ncbi.nlm.nih.gov/pubmed/24099345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-13-468
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars